Converting a Staphylococcus aureus Toxin into Effective Cyclic Pseudopeptide Antibiotics

Abstract : Staphylococcus aureus produces peptide toxins that it uses to respond to environmental cues. We previously characterized PepA1, a peptide toxin from S. aureus, that induces lytic cell death of both bacterial and host cells. That led us to suggest that PepA1 has an antibacterial activity. Here, we demonstrate that exogenously provided PepA1 has activity against both Gram-positive and Gram-negative bacteria. We also see that PepA1 is significantly hemolytic, thus limiting its use as an antibacterial agent. To overcome these limitations, we converted PepA1 into nonhemolytic derivatives. Our most promising derivative is a cyclic heptapseudopeptide with inconsequential toxicity to human cells, enhanced stability in human sera, and sharp antibacterial activity. Mechanistically, linear and helical PepA1 derivatives form pores at the bacterial and erythrocyte surfaces, while the cyclic peptide induces bacterial envelope reorganization, with insignificant action on the erythrocytes. Our work demonstrates that bacterial toxins might be an attractive starting point for antibacterial drug development.
Type de document :
Article dans une revue
Chemistry and Biology, 2015, Chemistry and Biology, 22 (3), pp.329-335. 〈10.1016/j.chembiol.2014.12.016〉
Liste complète des métadonnées

Littérature citée [28 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01125610
Contributeur : Annick Lefevre <>
Soumis le : vendredi 6 mars 2015 - 11:20:02
Dernière modification le : mercredi 16 mai 2018 - 11:24:00
Document(s) archivé(s) le : dimanche 7 juin 2015 - 17:15:36

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Citation

Olivia Solecki, Mosbah Amor, Michèle Baudy Floc'H, Brice Felden. Converting a Staphylococcus aureus Toxin into Effective Cyclic Pseudopeptide Antibiotics. Chemistry and Biology, 2015, Chemistry and Biology, 22 (3), pp.329-335. 〈10.1016/j.chembiol.2014.12.016〉. 〈inserm-01125610〉

Partager

Métriques

Consultations de la notice

469